The extracellular matrix in breast cancer

Insua-Rodríguez, Jacob, Oskarsson, Thordur·2016·Advanced Drug Delivery Reviews
DOI 10.1016/j.addr.2015.12.017

Cites (230)

Items 201–230 of 230

  1. Angiogenic characteristics of circulating and tumoural thrombospondin-1 in breast cancer
    Nigel James Bundred, S. Kumar, L. C. Tetlow · 2007 · International Journal of Oncology
  2. SPARC (Osteonectin) in Breast Tumors of Different Histologic Types and Its Role in the Outcome of Invasive Ductal Carcinoma
    Yi‐Hsuan Hsiao, Huang‐Chun Lien, Hsiao‐Lin Hwa · 2010 · The Breast Journal
  3. Integrin β4 Regulates SPARC Protein to Promote Invasion
    Kristin D. Gerson, Jeffrey R. Shearstone, V. S. R. K. Maddula, Bruce E. Seligmann, Arthur M. Mercurio · 2012 · Journal of Biological Chemistry
  4. Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence
    Agnieszka Katarzyna Witkiewicz, Boris Freydin, Inna Chervoneva, Magdalena Potoczek, Wendy Rizzo, Hallgeir Rui, Jonathan Robert Brody, Gordon Francis Schwartz, Michael P. Lisanti · 2010 · Cancer Biology & Therapy
  5. Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer
    Lixin Zhang, Jason A. Ngo, Michael D. Wetzel · 2015 · Neoplasia
  6. Expression of different proteoglycans in human breast tumors
    Tatiana Eshchenko, Valentina Ivanovna Rykova, Alexei Chernakov · 2007 · Biochemistry (Moscow)
  7. Periostin suppression induces decorin secretion leading to reduced breast cancer cell motility and invasion
    Toshiyuki Ishiba, Makoto Nagahara, Tsuyoshi Nakagawa, Takanobu Sato, Toshiaki Ishikawa, Hiroyuki Uetake, Kenichi Sugihara, Yoshio Miki, Akira Nakanishi · 2014 · Scientific Reports
  8. Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis
    Thomas J. Kelly, Larry J. Suva, Kristy M. Nicks · 2010 · Journal of Bone and Mineral Research
  9. Rat Mammary Extracellular Matrix Composition and Response to Ibuprofen Treatment During Postpartum Involution by Differential GeLC-MS/MS Analysis
    J. O'Brien, L. Vanderlinden, P. Schedin, Kirk C. Hansen · 2012 · Journal of Proteome Research
  10. IGFBP-3 Can Either Inhibit or Enhance EGF-mediated Growth of Breast Epithelial Cells Dependent upon the Presence of Fibronectin
    Jamie McIntosh, Godwin Dennison, Jeff M.P. Holly · 2010 · Journal of Biological Chemistry
  11. sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration
    Gema Martin‐Manso, María José Calzada, Yoshiro Chuman, John M. Sipes, Charles P. Xavier, Vladimir Wolf, Svetlana A. Kuznetsova, Jeffrey S. Rubin, David D. Roberts · 2011 · Archives of Biochemistry and Biophysics
  12. Laminin 332 Expression in Breast Carcinoma
    Soon Young Kwon, Seoung Wan Chae, Sharon Poltis Wilczynski, Ahmad Arain, Philip M. Carpenter · 2011 · Applied immunohistochemistry & molecular morphology
  13. Syndecan-1 ectodomain regulates matrix-dependent signaling in human breast carcinoma cells
    Brandon J. Burbach, Yan Ji, Alan C. Rapraeger · 2004 · Experimental Cell Research
  14. Improved Tumor Targeting by Combined Use of Two Antitenascin Antibodies
    Fiorella Petronzelli, Angela Pelliccia, Anna Maria Anastasi et al. · 2005 · Clinical Cancer Research
  15. Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study
    Jianghao Chen, Qing Yao, Dong Li, Juliang Zhang, Ting Wang, Ming Yu, Xiaodong Zhou, Yi Huan, Jing Wang, Ling Wang · 2013 · BMC Cancer
  16. Tamoxifen Induces Heparanase Expression in Estrogen Receptor–Positive Breast Cancer
    Irit Cohen, Bella Maly, Itamar Simon, Amichay Meirovitz, Eli Pikarsky, Eyal Zcharia, Tamar Peretz, Israël Vlodavsky, Michael Elkin · 2007 · Clinical Cancer Research
  17. Transgenic Mammary Epithelial Osteopontin (Spp1) Expression Induces Proliferation and Alveologenesis
    Neil E. Hubbard, Q. J. Chen, L. K. Sickafoose · 2013 · Genes & Cancer
  18. Expression of osteonectin mRNA in human breast tumours is inversely correlated with oestrogen receptor content
    J. Dinny Graham, Rosemary L. Balleine, Jane S. Milliken, A. Michael Bilous, Christine L. Clarke · 1997 · European Journal of Cancer
  19. Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency
    Fei Feng, Susan R. Rittling · 2000 · Breast Cancer Research and Treatment
  20. Lumican Exhibits Anti-Angiogenic Activity in a Context Specific Manner
    Bikram Sharma, Megan D. Ramus, Christopher T. Kirkwood · 2013 · Cancer Microenvironment
  21. Mammary Branching Morphogenesis Requires Reciprocal Signaling by Heparanase and MMP‐14
    Angélica Maciel Gomes, Ramray Bhat, Ana Luísa Correia · 2015 · Journal of Cellular Biochemistry
  22. Low and High Tenascin-Expressing Tumors Are Efficiently Targeted by ST2146 Monoclonal Antibody
    Rita De Santis, Claudio Albertoni, Fiorella Petronzelli et al. · 2006 · Clinical Cancer Research
  23. Cathepsin L plays an active role in involution of the mouse mammary gland
    Michael A. Burke, Dorothy Hutter, Rita P. Reshamwala, Janice E. Knepper · 2003 · Developmental Dynamics
  24. Anti-Tumor Effect of a Novel Soluble Recombinant Human Endostatin: Administered as a Single Agent or in Combination with Chemotherapy Agents in Mouse Tumor Models
    Zhihua Ren, Yanan Wang, Wenhong Jiang, Wei Hao Dai, Yongping Jiang · 2014 · PLoS ONE
  25. Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in androgen receptor-positive molecular apocrine-like tumors with reduced Notch1 activity
    Roshan K. Sriram, Vivian Lo, Benjamin R. Pryce, Lilia Antonova, Alan J. Mears, Manijeh Daneshmand, Bruce C. McKay, Simon James Conway, William J. Muller, Luc A. Sabourin · 2015 · Breast Cancer Research
  26. Heparanase and COX-2 expression as predictors of lymph node metastasis in large, high-grade breast tumors.
    Stephanie Gawthorpe, James E. P. Brown, Muhammad Arif, Peter Nightingale, Alan Michael Nevill, Amtul Razzaq Carmichael · 2014 · PubMed
  27. Src inhibitors in breast cancer therapy
    S. Hiscox, R. Nicholson · 2008 · Expert Opinion on Therapeutic Targets
  28. Inhibitory effect of endostatin combined with paclitaxel-cisplatin on breast cancer in xenograft-bearing mice
    Jianguo Sun, Li Deng, Yu‐zhong Duan · 2011 · Experimental and Therapeutic Medicine
  29. Aberrant type I and type III collagen gene expression in human breast cancerin vivo
    Kauppila, Saila, Stenbäck, Frej, Risteli, Juha, Jukkola, Arja, Risteli, Leila · 1998 · The Journal of Pathology
  30. Untitled work
    1998 · 10.1002/(sici)1097-0142(19980915)83:6